SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ubrx who wrote (1276)5/29/1999 12:41:00 PM
From: Firenze  Read Replies (1) of 1837
 
Jim,
Don't look for big profit margins on this drug. Maybe $0.08-0.12 per tablet. It should be looked at as a product that helps compliment the DRMD product line. The margins on this product are very low and the product is in a competitive group (Calcium Channel Blockers). Also, the only marketed brand product is Covera HS, which can not be substitutued with the DRMD verapamil in most states, because it uses a different dissolution technology.
Firenze
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext